Effects of urogastrone-epidermal growth factor on intestinal brush border enzymes and mitotic activity.

R A Goodlad, K B Raja, T J Peters, N A Wright

Department of Histopathology, Royal Postgraduate Medical School, Imperial Cancer Research Fund Histopathology Unit, London.

The wet weight of the stomach, small intestine, caecum, and colon were significantly reduced (p less than 0.001) in intravenously fed rats compared with orally fed controls. Human epidermal growth factor (urogastrone) reversed this atrophy. Detailed analysis of the small intestine showed a similar effect on intestinal crypt cell population, mitoses per crypt, and protein content. Brush border gamma glutamyltransferase and alpha glucosidase activities were reduced by up to 50% throughout the small intestine of the animals fed intravenously. The specific activities (mU/mg protein) were unchanged, as a concomitant decrease in the tissue weight and protein content also occurred. Intestinal brush border enzyme activities in the rats treated with urogastrone-epidermal growth factor were restored to those seen in the orally fed rats except for alpha glucosidase activity in the proximal gut. In addition, the specific activity of gamma glutamyltransferase was highly significantly increased (p less than 0.01) in all regions of the small intestine. Thus, although urogastrone administration prevents the decrease in brush border enzyme activity seen after the removal of luminal nutrition, the response seems to differ depending on the intestinal location, with the specific activities of some enzymes being higher than those seen in orally fed rats. Urogastrone-epidermal growth factor can thus significantly increase the functional ability of the intestine in addition to its trophic effects.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Beltinger, J., Hawkey, C. J., Stack, W. A. (1999). TGF-alpha reduces bradykinin-stimulated ion transport and prostaglandin release in human colonic epithelial cells. Am. J. Physiol. Cell Physiol. 276: C848-C855 [Abstract] [Full Text]  
• Buret, A., Olson, M. E., Gall, D. G., Hardin, J. A. (1998). Effects of Orally Administered Epidermal Growth Factor on Enteropathogenic Escherichia coli Infection in Rabbits. Infect. Immun. 66: 4917-4923 [Abstract] [Full Text]  
• Reindel, J. F., Pilcher, G. D., Gough, A. W., Haskins, J. R., De La Iglesia, F. A. (1996). Recombinant Human Epidermal Growth Factor1-48-Induced Structural Changes in the Digestive Tract of Cynomolgus Monkeys (Macaca fascicularis). Toxicol Pathol 24: 669-680 [Abstract]